Rigel Pharma (RIGL) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $41.30 -2.94%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
CCEL, MHGU, PLG, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $3.93 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Jefferies bullish on Deckers Outdoor, sees HOKA growth slowdown as oversold
- Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
